Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Associated Press· 1 hour agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
MTG Comes Unglued, Turns Fauci Hearing Into Absolute Sh*tshow
The Daily Beast· 2 days agoRep. Greene sneered and snickered at the former White House adviser, demanding he be imprisoned and...
Meghan Markle and Prince Harry Not Invited to Trooping the Colour for Second Year in a Row
People via Yahoo News· 1 day agoThe Duke and Duchess of Sussex didn't join the royal family for the first birthday parade of King...
"I'm not addressing him as doctor": Fauci hearing gets heated as MTG berates, hecklers are removed
Axios· 2 days agoIt was Fauci's first appearance on Capitol Hill since 2022, when he ended a decades-long government...
The Push to Get More People Into Long COVID Studies
Medscape· 2 days agoLast spring, he enrolled in a clinical trial of a new long COVID therapy at Stanford University, and he's about to start another at the University of...
How Demi Lovato Found the “Light” After 5 In-Patient Health Treatments
E! News via Yahoo News· 1 day agoDemi Lovato—who has been open about her mental health and sobriety journey—shared what inspired her...
Three Putnam County towns to reallocate ARPA funds - Mid Hudson News
Mid Hudson News· 6 days agoCARMEL – Three years ago, President Joe Biden signed the $1.9 trillion American Rescue Plan Act...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 2 days agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively flat plateau of blood ...
JD Supra: HHS Aligns Part 2 Substance Use Disorder Confidentiality Requirements With HIPAA
JD Supra· 5 days agoNewly effective regulations governing confidentiality of Substance Use Disorder (SUD) records now more closely mirror regulations implementing the Health Insurance Portability and...
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic...
Benzinga· 5 days agoAgency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval, under exceptional circumstances, of recombinant ADAMTS13 (rADAMTS13) for the treatment ...